Home Westgard multirule for calculated laboratory tests
Article
Licensed
Unlicensed Requires Authentication

Westgard multirule for calculated laboratory tests

  • Abdurrahman Coskun
Published/Copyright: September 21, 2011

Abstract

Background: In clinical laboratories, many test results such as low-density lipoprotein (LDL)-cholesterol can be calculated using the results of specifically measured tests. However, quality control programs deal only with measured tests and there is no adequate quality assessment procedure for calculated tests. I aimed to apply the Westgard multirule to calculated tests as a part of routine quality procedures.

Methods: I prepared a Levey-Jennings chart for calculated tests and all their measured components (Equation chart) and then applied the Westgard multirule to these tests.

Results: Applying the Westgard multirule to calculated LDL-cholesterol (and other calculated tests) was simple, and increased the reliability of the results of the calculated tests.

Conclusions: Checking the reliability of only measured tests by quality control procedures before reporting patient results may be inadequate. Applying the Westgard multirule to calculated tests as part of total quality management will increase the reliability of test results.

Clin Chem Lab Med 2006;44:1183–7.


Corresponding author: Abdurrahman Coskun, MD, Duzce University, School of Medicine, Department of Clinical Biochemistry, Konuralp-Duzce, Turkey Phone: +90-542-2380639, Fax: +90-380-5414105

References

1. Coskun A. The reliability of calculated laboratory tests. Clin Chem Lab Med 2005; 43:880–2.10.1515/CCLM.2005.148Search in Google Scholar PubMed

2. Coskun A. Modified Levey-Jennings charts for calculated laboratory tests. Clin Chem Lab Med 2006; 44:387–90.10.1515/CCLM.2006.066Search in Google Scholar PubMed

3. Coskun A. Six sigma and calculated laboratory tests. Clin Chem 2006; 52:770–1.10.1373/clinchem.2005.064311Search in Google Scholar PubMed

4. Rifai N, Warnick GR. Lipids, lipoproteins, apolipoproteins and other cardiovascular risk factors. In: Burtis CA, Ashwood ER, Bruns DE, editors. Tietz textbook of clinical chemistry and molecular diagnostics. St. Louis, MO: Elsevier Saunders Inc., 2006:903–81.Search in Google Scholar

5. Westgard JO, Barry PL, Hunt MR, Groth T. A multirule Shewhart chart for quality control in clinical chemistry. Clin Chem 1981; 27:493–501.10.1093/clinchem/27.3.493Search in Google Scholar

Received: 2006-5-16
Accepted: 2006-7-10
Published Online: 2011-9-21
Published in Print: 2006-10-1

©2006 by Walter de Gruyter Berlin New York

Articles in the same Issue

  1. Multiplexed testing in the autoimmunity laboratory
  2. Uncertainty calculation for calibrators and controls of laboratory diagnostic assays
  3. Westgard multirule for calculated laboratory tests
  4. Frequency of a single nucleotide (A2317G) and 56-bp variable number of tandem repeat polymorphisms within the deoxyribonuclease I gene in five ethnic populations
  5. The influence of genetic polymorphisms of cytochrome P450 3A5 and ABCB1 on starting dose- and weight-standardized tacrolimus trough concentrations after kidney transplantation in relation to renal function
  6. Apolipoprotein B gene 3′VNTR polymorphism: association with plasma lipids and coronary heart disease in Han Chinese
  7. Paraoxonase-1 (PON1) activity, but not PON1Q192R phenotype, is a predictor of coronary artery disease in a middle-aged Serbian population
  8. A modified method of prothrombin time/International Normalised Ratio determination in capillary blood and monitoring oral anticoagulant therapy
  9. Inhibition of the ubiquitin-proteasome system: a new avenue for atherosclerosis
  10. Lipid peroxidation and antioxidative status in β-thalassemia major patients with or without hepatitis C virus infection
  11. Role of serum S100B as a predictive marker of fatal outcome following isolated severe head injury or multitrauma in males
  12. Preanalytical and analytical variation of surface-enhanced laser desorption-ionization time-of-flight mass spectrometry of human serum
  13. Effect of nitrogen mustard, a vesicant agent, on lymphocyte energy metabolism
  14. Partitioning reference values of several Gaussian subpopulations with unequal prevalence – a procedure with computer program support
  15. Biovariability of plasma adiponectin
  16. Multicentre evaluation of a new point-of-care test for the determination of NT-proBNP in whole blood
  17. Innotrac Aio!: a point-of-care or a routine analyzer? Analytical performance and plasma/whole blood comparison
  18. Serologic associations of anti-cytoplasmic antibodies identified during anti-nuclear antibody testing
  19. The importance of metrological traceability on the validity of creatinine measurement as an index of renal function: International Federation of Clinical Chemistry and Laboratory Medicine (IFCC)
  20. Effect of seropositive rheumatoid factor on cardiac troponin I measurement using the Access® Immunoassay Analyzer
Downloaded on 29.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2006.233/html
Scroll to top button